Home › Calculator › ADAG Dividend Calculator 2026
ADAG Dividend DRIP Calculator 2026
52.22% YieldHealthcareAdagene Inc. · NASDAQ
Price: $3.83 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When ADAG pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your ADAG snowball 📈
$10,000 in ADAG → $16.58M in 10 years · $704.29/month
About Adagene Inc. (ADAG) — Dividend Analysis 2026
Adagene Inc. functions as a clinical-stage biopharmaceutical organization, primarily concentrating on the identification, evolution, and fabrication of monoclonal antibody-based therapeutics engineered to combat various types of cancer. The company's developmental pipeline encompasses several investigational assets currently undergoing human trials. Among these is ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibody, which is navigating Phase 1b/2 clinical assessment for individuals with advanced solid tumors and non-Hodgkin's lymphoma. Additionally, Adagene is progressing ADG126, a fully-human anti-CTLA-4 mAb, and ADG116, another human ligand-blocking anti-CTLA-4 mAb, both of which are advancing through Phase 1 studies for the treatment of advanced or metastatic solid tumors. Further along, ADG104, an anti-PD-L1 mAb, is in Phase 2 clinical development, and the innovative anti-CSF-1R mAb, ADG125, is undergoing Phase 1 trials. Beyond its clinical-stage programs, the firm also maintains an active preclinical portfolio. This includes ADG206, a masked, Fc engineered anti-CD137 agonistic POWERbody; ADG153, a masked anti-CD47 IgG1 SAFEbody, which is being explored for hematologic and solid tumor indications; ADG138, a novel HER2xCD3 POWERbody designed to target HER2-expressing solid tumors; and ADG152, a CD20xCD3 POWERbody under investigation for its potential to minimize off-tumor toxicities. Adagene Inc. was founded in 2011 and its principal operations are based in Suzhou, China.
Compare ADAG with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full ADAG DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ADAG position with:
🌍 ADAG Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold ADAG.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 52.22% | 49.42% | $5,222 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 44.39% | 41.59% | $4,439 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 41.78% | 38.98% | $4,178 / yr |
| 🇬🇧 UK ISA | 0% | 52.22% | 49.42% | $5,222 / yr |
| 🇬🇧 UK Taxable | 8.75% | 47.65% | 44.85% | $4,765 / yr |
| 🇨🇦 TFSA | 0% | 52.22% | 49.42% | $5,222 / yr |
| 🇨🇦 CA Taxable | 25% | 39.16% | 36.37% | $3,917 / yr |
| 🇦🇺 Super (pension) | 15% | 44.39% | 41.59% | $4,439 / yr |
| 🇦🇺 AU Taxable | 30% | 36.55% | 33.75% | $3,655 / yr |
| 🇩🇪 DE Taxable | 26.375% | 38.45% | 35.65% | $3,845 / yr |
| 🇫🇷 FR Taxable | 30% | 36.55% | 33.75% | $3,655 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 ADAG Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 ADAG Dividend Payment Schedule
ADAG pays quarterly — 4 times per year. Next ex-div: TBD.
📊 ADAG vs Healthcare Benchmarks
How ADAG compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ADAG sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ ADAG Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Other | 2026-03-18 | 400,000 | $1.38 | $550.4K | ||
| Other | 2026-03-18 | 400,000 | $2.03 | $812.8K | ||
| Other | 2026-03-02 | 250,000 | $4.00 | $1.00M | ||
| Other | 2026-03-18 | 100,000 | $2.03 | $203.2K | ||
| Other | 2026-03-18 | 50,000 | $1.04 | $52.0K | ||
| Other | 2026-03-18 | 138,519 | $1.48 | $205.0K | ||
| Other | 2026-03-18 | 74,886 | $1.83 | $137.0K | ||
| Other | 2026-03-18 | 40,000 | $1.33 | $53.2K | ||
| Other | 2026-03-18 | 252,448 | $1.73 | $436.7K | ||
| Other | 2026-03-18 | 50,000 | $1.55 | $77.5K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ADAG dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Adagene Inc. (ADAG) is currently trading at $3.83, 87% below its 52-week high. The current dividend yield is 52.22% based on an annual payout of $2.00 per share.
ADAG (Adagene Inc.) — 52.22% Dividend Yield Analysis
Adagene Inc. (ADAG) is a healthcare stock currently trading at $3.83 with a dividend yield of 52.22%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (52.22%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.